Objectives The goal of this systematic review and meta-analysis was to provide a
comprehensive evaluation of contemporary randomized trials addressing the efficacy and …

Coronary disease carries significant morbidity and mortality globally. The pandemic of
obesity and diabetes combined with an aging population have resulted in a significant …

Background: A large proportion of patients presenting with non–ST-segment elevation
myocardial infarction (NSTEMI) present with multivessel disease (MVD). There is uncertainty …

Recent randomized controlled trials have suggested that patients with ST-segment elevation
myocardial infarction and multivessel coronary artery disease may benefit more from …

Approximately 50% of patients with ST-segment elevation myocardial infarction (STEMI)
have multivessel disease. The optimal reperfusion strategy in these patients is still uncertain …

Background Up to half of patients undergoing percutaneous coronary intervention have
multivessel coronary artery disease (MVD) with conflicting data regarding optimal …

Background Studies have suggested that complete revascularization is superior to culprit‐
only revascularization for the treatment of enzyme‐positive acute coronary syndrome …

背景对于急性心肌梗死合并多支血管病变的治疗, 目前主要有单纯罪犯血管血运重建及完全血运
重建两种方法, 虽然许多系统评价对比了这两种治疗方法的有效性和安全性 …

Background The best approach for revascularization of multi-vessel coronary disease in
patients with ST-elevation myocardial infarction (STEMI) undergoing primary percutaneous …

Background Guidelines suggest percutaneous intervention (PCI) of only the culprit artery in
patients presenting with ST-segment elevation myocardial infarction (STEMI) and …